Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D. (IMAGE)

Medical University of South Carolina

Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D.

Caption

A new study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, sheds light on why pancreatic tumors with the KRAS G12R mutation behave differently from other KRAS-driven cancers and why patients with these tumors tend to have better outcomes. 

Credit

Medical University of South Carolina

Usage Restrictions

Use with credit to MUSC.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.